Ventilation mode performance against airborne respiratory infections in small office spaces: limits and rational improvements for Covid-19

被引:0
|
作者
Bruno Perazzo Pedroso Barbosa
Nisio de Carvalho Lobo Brum
机构
[1] Department of Architecture and Engineering-DAE,Department of Mechanical Engineering
[2] FIOCRUZ,LTTC
[3] Federal University of Rio de Janeiro,Laboratory of Heat Transfer and Technology
[4] Federal University of Rio de Janeiro,undefined
关键词
Covid-19; Infection control; Office; CFD; Ventilation; Airborne;
D O I
暂无
中图分类号
学科分类号
摘要
The Coronavirus disease (Covid-19), caused by the SARS-CoV-2 virus, has produced significant social and economic disruptions in different countries. Current evidence suggests a strong correlation between the infection and the cohabitation of indoor spaces. International organizations and experts consider that the airborne transmission through aerosols can occur in specific conditions and that inadequate ventilation increases the risk of infection. As a result, the increase in ventilation rates and air filtration efficiencies are recommended for public buildings in the context of Covid-19, with significant impacts on energy consumption, and a paradigm shift in the design of ventilation systems is necessary for this new context. Therefore, this study has assessed the comparative performance of the displacement ventilation and the mixed ventilation mode on reducing the risk of long-range airborne infection for the Covid-19 in a small office application. A coupled multizone-CFD (Computational Fluid Dynamics) software developed by the National Institute of Standards and Technology was used in this study to assess the relative performance of several design solutions related to different ventilation modes, filter efficiencies, and outdoor air flow rates. The results demonstrate that the displacement ventilation technique produces a better overall performance in reducing the SARS-CoV-2 airborne infection risk than the conventional mixed ventilation for all the studied cases.
引用
收藏
相关论文
共 31 条
  • [21] Long Term Impact of Adeno-tonsillectomy on Immunity Against Respiratory Viral Infections; Evidence Deduced During COVID-19 Pandemic: Correspondence
    Petros V. Vlastarakos
    Giorgos Sideris
    Evangelos Panagoulis
    Melina Kourklidou
    Alexandra Karakasi
    Sotirios Karamagkiolas
    Indian Journal of Pediatrics, 2025, 92 (4): : 426 - 426
  • [22] Long Term Impact of Adeno-tonsillectomy on Immunity Against Respiratory Viral Infections; Evidence Deduced During COVID-19 Pandemic: Authors' Reply
    Sagar, Prem
    Murugesan, Ramaneeshwaran
    Kumar, Rajeev
    INDIAN JOURNAL OF PEDIATRICS, 2025, 92 (04): : 427 - 427
  • [23] Oropharyngeal Probiotic ENT-K12 Prevents Respiratory Tract Infections Among Frontline Medical Staff Fighting Against COVID-19: A Pilot Study
    Wang, Qiang
    Lin, Xuan
    Xiang, Xiaochen
    Liu, Wanxin
    Fang, Ying
    Chen, Haiping
    Tang, Fang
    Guo, Hongyan
    Chen, Di
    Hu, Xiafen
    Wu, Qingming
    Zhu, Baoli
    Xia, Junbo
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2021, 9
  • [24] Extraction of niclosamide from commercial approved tablets into aqueous buffered solution creates potentially approvable oral and nasal sprays against COVID-19 and other respiratory infections
    David Needham
    AAPS Open, 9 (1)
  • [25] Vaccine effectiveness against severe acute respiratory infections (SARI) COVID-19 hospitalisations estimated from real-world surveillance data, Slovenia, October 2021
    Vitek, Marta Grgic
    Klavs, Irena
    Ucakar, Veronika
    Serdt, Mojca
    Mrzel, Maja
    Vrh, Marjana
    Fafangel, Mario
    EUROSURVEILLANCE, 2022, 27 (01)
  • [26] Vitamin D, acute respiratory infections, and Covid-19: The curse of small-size randomised trials. A critical review with meta-analysis of randomised trials
    Autier, Philippe
    Doi, Giulia
    Mullie, Patrick
    Vankrunkelsven, Patrick
    D'Ecclesiis, Oriana
    Gandini, Sara
    PLOS ONE, 2025, 20 (01):
  • [27] Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections
    Timo Huber
    Philipp Steininger
    Pascal Irrgang
    Klaus Korn
    Matthias Tenbusch
    Katharina Diesch
    Susanne Achenbach
    Andreas E. Kremer
    Marissa Werblow
    Marcel Vetter
    Christian Bogdan
    Jürgen Held
    European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 1983 - 1997
  • [28] Correction to: Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections
    Timo Huber
    Philipp Steininger
    Pascal Irrgang
    Klaus Korn
    Matthias Tenbusch
    Katharina Diesch
    Susanne Achenbach
    Andreas E. Kremer
    Marissa Werblow
    Marcel Vetter
    Christian Bogdan
    Jürgen Held
    European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 1999 - 2004
  • [29] Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
    Choudhry, Namrta
    Zhao, Xin
    Xu, Dan
    Zanin, Mark
    Chen, Weisan
    Yang, Zifeng
    Chen, Jianxin
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (22) : 13205 - 13227
  • [30] Kakkonto, shosaikoto, Platycodon grandiflorum root, and gypsum (a Japanese original combination drug known as saikatsugekito): Pharmacological review of its activity against viral infections and respiratory inflammatory conditions and a discussion of its applications to COVID-19
    Arita, Ryutaro
    Ono, Rie
    Saito, Natsumi
    Takayama, Shin
    Namiki, Takao
    Ito, Takashi
    Ishii, Tadashi
    TRADITIONAL & KAMPO MEDICINE, 2020, 7 (03) : 115 - 127